EUVIMEDEUVIMED entdecken
Systematische ÜbersichtÜbersichtsarbeitOpen Access · CC BY 4.0

Tracking Genetic Parkinson's Disease with Molecular Imaging: A Systematic Review

Chiara Meneghini, Luca Gallo, Arianna Sala, Enza Maria Valente iD, Micol Avenali iD, Silvia Paola Caminiti

Movement Disorders Clinical Practice · 2026

DOI: 10.1002/mdc3.70687 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Movement Disorders Clinical Practice, 2026. Verfasst von Chiara Meneghini und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy. Hauptthemen laut MEDLINE: Parkinson Disease, Molecular Imaging, Brain. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 199 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero dell'Istruzione, dell'Università e della Ricerca, Ministry of Education, University and Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Parkinson's disease (PD) is a worldwide, complex neurodegenerative disorder influenced by both genetic and environmental factors. Around 15–20% of PD cases are linked to genetic mutations, providing insights into the disease's pathogenesis.

Objective

The current review aims to summarize molecular neuroimaging findings in genetic forms of PD, also considering the pre‐symptomatic phase of the disease to identify markers distinguishing genetic PD from sporadic forms of the disease as well as early markers of disease conversion.

Methods

A literature search on PubMed and Scopus was performed to identify molecular imaging studies on symptomatic and asymptomatic carriers of the following PD‐related mutations: SNCA , PRKN , PINK1 , PARK7 , LRRK2 and GBA1 .

Results

A total of 96 studies were summarized to highlight mutation‐specific brain alterations, considering dopaminergic and extra‐dopaminergic systems (serotonin, acetylcholine), metabolic and cerebral blood flow alterations as well as emerging evidence on beta‐amyloid, tau proteins and neuroinflammation.

Conclusions

Molecular neuroimaging techniques, including Positron Emission Tomography (PET) and Single Photon Emission computed tomography (SPECT), provide valuable tools for tracking PD pathophysiology in vivo. Indeed, nuclear imaging is able to add information on genetic PD, offering possible biomarkers to stratify patients, predict cognitive decline, and support personalized therapeutic approaches.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseMolecular ImagingBrainHumansalpha-SynucleinTomography, Emission-Computed, Single-PhotonMutationLeucine-Rich Repeat Serine-Threonine Protein Kinase-2Ubiquitin-Protein LigasesPositron-Emission TomographyPTEN-Induced Putative KinaseGlucosylceramidaseProtein KinasesProtein Deglycase DJ-1

Stichwörter der Autor:innen

biomarkerneuroimagingnuclear medicineparkinsonismprecision medicine

Substanzen

alpha-SynucleinLeucine-Rich Repeat Serine-Threonine Protein Kinase-2SNCA protein, humanUbiquitin-Protein LigasesPTEN-Induced Putative KinaseLRRK2 protein, humanGlucosylceramidaseProtein KinasesGBA protein, humanProtein Deglycase DJ-1

Autor:innen und Institutionen

  • Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy.
  • Coma Science Group, GIGA Consciousness, GIGA Institute, University of Liège, Liège, Belgium.
  • NeuroRecovery Lab, GIGA Consciousness, GIGA Institute, University of Liège, Liège, Belgium.
  • NeuroRehab & Consciousness Clinic, Neurology Department, University Hospital of Liège, Liège, Belgium.
  • IRCCS Mondino Foundation, Pavia, Italy.
  • Department of Molecular Medicine, University of Pavia, Pavia, Italy.

ORCID-Profile: Enza Maria Valente, Micol Avenali

Förderung

  • Ministero dell'Istruzione, dell'Università e della Ricerca
  • Ministry of Education, University and Research

Zitieren

APA

Meneghini, C., Gallo, L., Sala, A., Valente, E. M., Avenali, M., & Caminiti, S. P. (2026). Tracking Genetic Parkinson's Disease with Molecular Imaging: A Systematic Review. Movement Disorders Clinical Practice. https://doi.org/10.1002/mdc3.70687

Vancouver

Meneghini C, Gallo L, Sala A, Valente EM, Avenali M, Caminiti SP. Tracking Genetic Parkinson's Disease with Molecular Imaging: A Systematic Review. Movement Disorders Clinical Practice. 2026. doi:10.1002/mdc3.70687

BibTeX
@article{Meneghini2026,
  author = {Meneghini, Chiara and Gallo, Luca and Sala, Arianna and Valente, Enza Maria and Avenali, Micol and Caminiti, Silvia Paola},
  title = {Tracking Genetic Parkinson's Disease with Molecular Imaging: A Systematic Review},
  journal = {Movement Disorders Clinical Practice},
  year = {2026},
  doi = {10.1002/mdc3.70687}
}
Kostenlos starten →